Abstract
Introduction China’s immunization program has caused dramatic declines in morbidity and mortality from vaccine-preventable diseases (VPDs). To further evaluate the program’s achievements, we explored patterns in the morbidity and mortality of VPDs in China based on national surveillance data.
Methods According to the times at which vaccines were introduced and the history of the National Immunization Program (NIP), we divided the study period of 1950 to 2018 into four stages. Meningococcal meningitis, measles, polio, diphtheria, pertussis, tuberculosis, hepatitis B, hepatitis A, Japanese encephalitis (JE), mumps and rubella were analyzed as representative notifiable diseases in China, and annual surveillance data obtained between 1950 and 2018 were used to derive trends in the morbidity and mortality rates of the 11 diseases for each stage. Quasi-Poisson regression models were used to estimate the impacts of specific vaccine programs, and life-table methods were used to calculate the loss of life expectancy, years of life lost (YLLs) and loss of working years.
Results The total notification number for the 11 VPDs was 211,866,000 from 1950 to 2018. The greatest number occurred in 1959, with around 12 million cases and a total incidence rate of 1723 per 100,000 persons. The quasi-Poisson regression models showed that most of the 11 diseases revealed dramatic declines in both morbidity and mortality after a vaccine became available. From 1978 to 2018, the incidence of pertussis fell 98% from 126.35 to 1.58 per million, that of measles fell 99% from 249.76 to 0.28 per 100,000, that of meningococcal meningitis fell 99% from 32.23 to 0.01 per million, that of JE fell 98% from 5.39 to 0.13 per million, and diphtheria and polio were eradicated, with the last cases being reported in 2006 and 1994, respectively. From 1978 to 2018, the total life expectancy for the 11 VPDs increased by 0.79 years.
Conclusions China has had great success in controlling VPDs in recent decades, and the burden of major infectious diseases has been declining. The implementation of the National Immunization Program accelerated the decreases in the morbidity and mortality rates. Improving vaccination coverage is a key aspect of controlling diseases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
NONE
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board at the School of Public Health, Fudan University, approved the study protocol with a waiver of informed consent. Data were analyzed at aggregate level and no participants were contacted.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
This study was funded by the “Evaluation project on national immunization program of China”.
Data Availability
We constructed a standardized vaccine-preventable infectious disease dataset by extracting information from the National Disease Reporting System (NDRS). Data on the total population and natural deaths of the population were obtained from the China Statistical Yearbook. Data on vaccination coverage of Japanese encephalitis, meningococcal meningitis and hepatitis A were collected from national vaccination coverage surveys that were conducted in selected provinces. Data on vaccination rates for other diseases were obtained from the WHO website (http://apps.who.int/gho/data/node.main.A824?lang=en).
